Assertio (ASRT)
(Real Time Quote from BATS)
$1.20 USD
-0.03 (-2.44%)
Updated Aug 8, 2024 10:00 AM ET
3-Hold of 5 3
B Value D Growth C Momentum D VGM
Brokerage Reports
Assertio Holdings, Inc. [ASRT]
Reports for Purchase
Showing records 101 - 117 ( 117 total )
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Deep Value - Even with Conservative Assumptions
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
1Q19 Recap - Cosyntropin Noise, But Valuation Remains Compelling
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Purdue Settlement a Positive (Despite ST Reaction)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Updated Model - Modest Downward Revisions, but Still Undervalued
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.